M. Taton

发表

Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis.

R. Paschke, T. Velu, F. Schuppert, 1994, The Journal of endocrinology.

9166 Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations

L. Decoster, E. Teugels, C. Geers, 2009 .

Mitogenic effects of thyrotropin and adenosine 3',5'-monophosphate in differentiated normal human thyroid cells in vitro.

J. Dumont, P. Roger, J. van Sande, 1988, The Journal of clinical endocrinology and metabolism.

Mitogenic, dedifferentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells.

K. Matsumoto, T. Nakamura, J. Dumont, 1994, Endocrinology.

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours.

A. Awada, S. Bartholomeus, T. Gil, 2012, European journal of cancer.

Positive control of proliferation by the cyclic AMP cascade: An oncogenic mechnism of hyper-functional adenoma

M. Parmentier, C. Ledent, J. Parma, 1995, Journal of endocrinological investigation.

General inhibition by transforming growth factor β1 of thyrotropin and cAMP responses in human thyroid cells in primary culture

J. Dumont, F. Lamy, P. Roger, 1993, Molecular and Cellular Endocrinology.

Control of protein synthesis by thyrotropin and epidermal growth factor in human thyrocytes: Role of morphological changes

J. Dumont, F. Lamy, P. Roger, 1990, Molecular and Cellular Endocrinology.

Effector Vγ9Vδ2 T cell response to congenital Toxoplasma gondii infection

A. Marchant, D. Vermijlen, V. Meroni, 2021, JCI insight.

36 ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours

A. Awada, S. Bartholomeus, T. Gil, 2008 .

IGF-1 or insulin, and the TSH cyclic AMP cascade separately control dog and human thyroid cell growth and DNA synthesis, and complement each other in inducing mitogenesis

T. Nakamura, K. Coulonval, I. Pirson, 1999, Molecular and Cellular Endocrinology.

Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study

P. van Damme, A. Marchant, Bernardo A. Mainou, 2023, Vaccine.

Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization.

A. Marchant, M. Ackerman, F. Willems, 2023, Vaccine.

Final analysis of a phase I single dose-escalation study of the novel polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumors.

A. Awada, S. Bartholomeus, T. Gil, 2010 .

A phase I dose finding study of the 3-day administration of BIBW 2992, an irreversible dual EGFR/HER-2 inhibitor, in combination with three-weekly docetaxel in patients with advanced solid tumors.

M. Piccart, M. Uttenreuther-Fischer, A. Awada, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

11 The cAMP in thyroid

A. Allgeier, M. Parmentier, C. Ledent, 1997 .

Dissociation of the stimuli for cell hypertrophy and cell division in the dog thyrocyte: insulin promotes protein accumulation while TSH triggers DNA synthesis.

J. Dumont, M. Taton, 1995, Experimental cell research.

Regulation and metabolic role of phospholipase D activity in human thyroid and cultured dog thyrocytes.

P. Rocmans, J. Mockel, C. Lejeune, 1996, The Journal of clinical endocrinology and metabolism.

The TSH cyclic AMP cascade in the control of thyroid cell proliferation: the story of a concept.

C. Maenhaut, M. Taton, Marc Parmentier, 1991, Thyroidology.